coli (Algorithm 1; ICD-10-CM:A41.51; base case) as well as a broader, previously validated, claims-based algorithm for infectious invasive disease/organ dysfunction with concomitant E. coli infection (Algorithm 2; sensitivity analysis) [43]. Each of the algorithms is described in greater ...
In E. coli the quantities of MSase:ICLase:ICDHase-kinase/phosphatase are approximately 0.3:1:0.003. The moderate upshift in aceA when compared to aceB expression is due to differences in efficiency of translation, whereas the remarkable downshift in aceK expression seems to result from a ...
10. Chung HC, Lai CH, Lin JN, Huang CK, Liang SH, Chen WF, Shih YC, Lin HH, Wang JL: Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob ...
The afimbrial adhesin (afa) was found associated with bacteremia m ortality23. Only phylogroup B2 was significantly different between ESBL-ExPEC and non-ESBL-ExPEC. Similarly, the extended-spectrum cephalosporin resistant E. coli isolates belonging to phylogroup B2 carried ESBL and/or Ap...
bacteremia [14]. This dissemination has increased both in the hospital environment and in the community [18]. Some studies from Latin American countries have described the presence of ST131, both in hospitals and the community [19,20,21,22]. In Ecuador, a study ofE. coliserotype O25 ...
coli in the context of a human complement response was evaluated using an in vivo murine model of bacteremia. Results showed that curli production enhanced E. coli survival, which suggests that curli defends against complement-mediated killing. This observation was supported by the results of in ...
the number of admissions and the number of days of admissions related to infectious diseases were calculated based on the recorded diagnosis of the admission using ICD-10. A list of all included diagnoses is available in theSupplementary Materials, Table S1. We included year of analysis due to...
[15]. In SSA, ESBL-producingE. coliis increasingly recognised as a significant pathogen in invasive infections, such as bacteremia, posing a severe threat to clinical practice. ESBLs are plasmid-borne enzymes that hydrolyse β-lactam rings in penicillins, broad-spectrum cephalosporins, and mono...